BackSAB Biotherapeutics Overview

SAB Biotherapeutics Other Current Assets

SAB Biotherapeutics's other current assets is $3.5M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$3.46M
↓ 3.72% YoYΔ $-133569.00 vs prior year quarter

Peer average / median

Loading

SAB Biotherapeutics Other Current Assets History

Loading

SAB Biotherapeutics vs. peers: Other Current Assets Comparison

Loading

SAB Biotherapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

SAB Biotherapeutics (SABS) FAQ

SAB Biotherapeutics (SABS) currently reports a other current assets of $3.5M as of June 2026. That compares with $3.6M in the prior-year period — down 3.7% year over year. Use the charts on this page to explore SAB Biotherapeutics's other current assets history and peer comparisons.

SAB Biotherapeutics's other current assets decreased from $3.6M to $3.5M — a 3.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SAB Biotherapeutics reported $3.5M in other current assets as of June 2026. That compares with $3.6M in the prior-year period — down 3.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $3.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SAB Biotherapeutics, and consider following SABS for alerts when major investors trade the stock.